Search details
1.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 2024 May 31.
Article
in English
| MEDLINE | ID: mdl-38843860
2.
Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1-SSX3 gene fusion.
Genes Chromosomes Cancer
; 63(1): e23215, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38050902
3.
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Cancer
; 128(1): 85-93, 2022 Jan 01.
Article
in English
| MEDLINE | ID: mdl-34643947
4.
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 456-466, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32066540
5.
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
BMC Cancer
; 20(1): 99, 2020 Feb 05.
Article
in English
| MEDLINE | ID: mdl-32024476
6.
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 20(9): 1252-1262, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31331701
7.
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 20(1): 134-144, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30578023
8.
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Lancet Oncol
; 20(7): 1023-1034, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31160249
9.
Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results from the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS).
Oncologist
; 24(6): e338-e346, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30409793
10.
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
Invest New Drugs
; 36(3): 468-475, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29527631
11.
A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.
Anticancer Drugs
; 28(10): 1157-1165, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28926423
12.
Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST).
BMC Med Res Methodol
; 17(1): 135, 2017 Sep 07.
Article
in English
| MEDLINE | ID: mdl-28882125
13.
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
FASEB J
; 29(2): 464-76, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25359494
14.
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models.
Nanomedicine
; 12(7): 1987-1996, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27085904
15.
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 16(5): 531-40, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25864104
16.
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS).
Ann Surg Oncol
; 22(9): 2948-57, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25608769
17.
Differences between en bloc resection and enucleation of retroperitoneal sarcomas.
Cir Esp
; 92(8): 525-31, 2014 Oct.
Article
in English, Spanish
| MEDLINE | ID: mdl-24726340
18.
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
J Clin Oncol
; 42(8): 898-906, 2024 Mar 10.
Article
in English
| MEDLINE | ID: mdl-38232337
19.
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma.
Invest New Drugs
; 31(1): 145-51, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-22539091
20.
[Primary, non-metastatic gastrointestinal stromal tumour surgery: results of the GRISK study]. / Cirugía de los tumores del estroma gastrointestinal primarios no metastásicos. Resultados del estudio GRISK.
Cir Esp
; 91(2): 96-102, 2013 Feb.
Article
in Spanish
| MEDLINE | ID: mdl-22748847